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Molecular methods have emerged as the most reliable techniques to detect
and characterize pathogenic Escherichia coli. These molecular techniques include
conventional single analyte and multiplex PCR, PCR followed by microarray detection,
pulsed-field gel electrophoresis (PFGE), and whole genome sequencing. The choice of
methods used depends upon the specific needs of the particular study. One versatile
method involves detecting serogroup-specific markers by hybridization or binding to
encoded microbeads in a suspension array. This molecular serotyping method has been
developed and adopted for investigating E. coli outbreaks. The major advantages of this
technique are the ability to simultaneously serotype E. coli and detect the presence of
virulence and pathogenicity markers. Here, we describe the development of a family of
multiplex molecular serotyping methods for Shiga toxin-producing E. coli, compare their
performance to traditional serotyping methods, and discuss the cost-benefit balance of
these methods in the context of various food safety objectives.
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INTRODUCTION/BACKGROUND
In the U.S., Shiga toxin-producing Escherichia coli (STEC) represent a significant public health
concern causing approximately 175,000 illnesses annually (Scallan et al., 2011). The CDC estimates
the annual U.S. costs for acute care of STEC patients to be $1–2 billion (Paton and Paton, 2000
Science and Medicine p 28–37). Furthermore, STEC-related recalls are expensive for the food
industry. For example, the outbreak of E. coli O157 associated with spinach from California’s
Salinas Valley in 2006 cost farmers up to $200 million (Arnade et al., 2010). Although E. coli
O157 remains the most common STEC serogroup in the U.S. (Centers for Disease Control and
Prevention [CDC], 2011), over 200 additional E. coli serogroups exist (Hussein and Bollinger,
2005). Those non-O157 STEC are responsible for over 60% of the STEC infections (Scallan
et al., 2011). The clinical manifestations of STEC infections range from mild watery diarrhea to
severe complications of hemorrhagic colitis (HC), hemolytic uremic syndrome (HUS), and even
death (Levine et al., 1987; Gyles, 2007). Since not all STEC appear to cause illness, distinguishing
pathogenic STEC from the ones that do not pose a health risk remains a current challenge for
regulatory agencies worldwide. Certain STEC serogroups are more highly correlated with severe
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illness than others. For example, STEC O26, O45, O103, O111,
O121, and O145 are referred to as the “Big Six” and account
for 75–80% of non-O157 STEC isolations in clinical samples in
the U.S. (Gould et al., 2013). In addition, STEC O91, O113, and
O128 have also been previously reported to cause HC and HUS
(Johnson et al., 2006), and an STEC O104-caused outbreak in
Germany in 2011 sickened 3816 individuals, making it one of
the largest HUS outbreaks ever reported (Muniesa et al., 2012).
Thus rapidly identifying STEC belonging to those serogroups is
as important for protecting consumer health as early diagnosis
of STEC infection for determining the proper treatment (Gould
et al., 2009). Additionally, such rapid identification can alert
public health officials that an outbreak has occurred and aid
in matching clinical, food, and environmental isolates when
attempting to trace back to the source of contamination.
Traditional serotyping employs O-specific antisera, usually in
a slide agglutination format. These methods are quite simple,
robust, and rapid. However, they can be both labor-intensive
and time-consuming for large numbers of isolates, and may
lead to ambiguous results because of variability in antisera
production and a lack of standard methodology. Whereas slide
agglutination is also relatively inexpensive when only a few of the
most common antigens are tested, maintaining a complete set of
hundreds of antisera reagents for O serotyping is expensive and
most often left to central reference laboratories adding to the time
of analysis (Dijkshoorn et al., 2001). Currently, there is a need for
faster tests. One solution is to allow a food sample to be probed
simultaneously for specific STEC serogroups, which can then
be extracted from that food sample, thus completing detection
and isolation of STEC in foods within 24 h. Suspension array
technology using microbeads has been useful in filling this need
by enabling development of rapid, high-throughput adaptable
assays for identifying clinically relevant STEC O-serogroups.
These microbead-based assays can theoretically analyze up to 500
targets in a single reaction, so targets can be added or removed as
needed. For example, a 7-plex immunoassay was developed by
Clotilde et al. (2013) to identify O serogroups O26, O45, O103,
O111, O121, O145, and O157. The microbeads were also capable
of binding to live cells, which aides in isolating pathogenic
organisms for further characterization studies (Clotilde et al.,
2013). Another example is a 13-plex PCR-based suspension assay
to identify 11 O-serogroups: O26, O45, O91, O103, O104, O111,
O113, O121, O128, O145, and O157; and two virulence factors:
eae and aggR (Feng et al., 2015). These two assays are fast (<4 h),
high throughput (96 well format), and were able to identify STEC
serogroups more accurately than traditional serotyping (Clotilde
et al., 2015).
SUSPENSION ARRAY TECHNOLOGY
Microbead-based suspension array technology has emerged as a
standard method for simultaneously detecting multiple biological
analytes from one sample and has enabled a wide variety of
applications in life science research, clinical diagnostics, food
safety, and biodefense (McBride et al., 2003; Toro et al., 2013;
Sun et al., 2014; Di Cristanziano et al., 2015; Khalifian et al.,
2015; Silbereisen et al., 2015; Zhang et al., 2015; Kong et al.,
2016). Commercial assay kits are available for cytokine profiling,
infectious disease diagnostics, genotyping for inherited diseases,
food pathogen typing, organ transplant compatibility testing,
and many more. Many of these kits are built on the Luminex R©
xMAP R© multiplexing platform, which utilizes fluorescent dyes to
create sets of microbeads with unique spectral identities. Unique
capture molecules are coupled to each set of microbeads, which
then capture different analytes of interest. After binding to a
detector molecule, which subsequently binds to a fluorescent
reporter, these microbeads are read in a flow cytometer such
as the Luminex R© 200TM or FLEXMAP 3D R© instrument, or in
a bead imager such as the Luminex MAGPIX R© instrument to
determine both the presence and quantity of analyte(s) in the
sample. The Luminex systems are capable of detecting up to 50,
100, or 500 different analytes from one sample in the MAGPIX,
Luminex 200, or FLEXMAP 3D instruments, respectively. Some
advantages of suspension array platforms include fast kinetics
due to mobile capture surfaces, broad dynamic range (>3 logs),
and high precision due to multiple independent measurements
on many microbeads for each analyte in the sample. Open
platform suspension array systems also enable researchers and
other biomedical professionals to design and build tests for
their specific applications. In the area of food safety discussed
here, an important aspect of suspension array technology is the
ability to detect DNA, RNA, and protein targets with the same
system.
IMMUNOASSAY/PROTEIN BASED
SEROTYPING
Inoculation of E. coli produces a strong immune response, which
targets immunodominant antigens, such as lipopolysaccaride
(O-antigens) and flagellum (H-antigens). The best-known E. coli
serotype is O157:H7. Strains sharing the O157 O-antigen (i.e.,
members of the O157 serogroup) also tend to share pathogenic
phenotypes. For example, most strains belonging to the O157
serogroup exhibit prophages that code for Shiga toxin (Stx).
Other serotypes may also carry Stx-encoding phage, and in the
US seven STEC serogroups are considered adulterants in foods:
O26, O111, O103, O121, O45, O145, and O157. Although there
are particular strains within these serogroups that do not produce
Stx, all are grounds for regulatory actions, including product
recalls. Thus the food industries have considerable interest in
E. coli serogroup testing.
Identification of specific E. coli serotypes is important for
tracing infections to their environmental source. Outbreaks
were formerly detected and defined solely by the serogroup of
pathogens, and serotyping still provides a rapid and inexpensive
means for preliminary characterization. Until recently the “gold
standard” for serotyping was slide agglutination with O and H
antigen specific antisera (Orskov et al., 1977; Machado et al.,
2000). Now, alternative immunochemical assay formats are also
available, including our Luminex-format microbead suspension
array as a solid phase for multiplex typing of various STEC
serogroups. (See Figure 1A).
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FIGURE 1 | Two microbead-based approaches for characterization of
STEC. (A) Sandwich immunoassay techniques targeting cell-surface
antigens. (B) Molecular (gene-based) techniques targeting specific genetic
markers of serogroup and virulence. Only four microbead regions are shown,
with each region targeting a specific STEC serogroup.
Our assay architecture is similar to a sandwich ELISA,
starting with an antibody (Ab) that is bound to a solid phase
support. In a typical ELISA, this “capture Ab” is non-covalently
adsorbed to a microplate well, but we use covalent attachment.
When the target is added, the capture antibody can bind and
pull its antigen out of the solution phase. Next the detector
Ab is added, which binds to the antigen to create the Ab
sandwich configuration. Finally the detector Ab is detected by
means of a probe. In ELISA, that probe is labeled with an
enzyme. In our assay, the probe is labeled with phycoerythrin,
a bright fluorophore. Because bacteria exhibit many copies of
O-antigen, the same Ab may be used for both capture and
detection.
To generate the assay reagents, magnetic microbeads
were covalently coupled to capture Ab according to the
instructions provided with the BioRad Amine Coupling kit
(BioRad, Hercules, CA, USA), using an amount of Ab based
on a preliminary microplate ELISA data (1–10 µg/mL). This
reaction is a common two-step carbodiimide protocol with
N-hydroxysulfosuccinimide. Coupling was confirmed using
phycoerythrin-labeled anti-species Ab. Detector Ab were
biotinylated with the EZ-Link Sulfo-NHS-Long Chain-Biotin
kit (Pierce, Rockford, IL, USA), according to the manufacturer’s
instructions. Coupled microbeads and detector Ab were stable at
2–8◦C for up to 1 year.
Samples were generated by blending foods at a 1:10 dilution
into Brain Heart Infusion broth. A 1mL aliquot was then spiked
with ∼10 CFU of E. coli and incubated overnight shaking at
25 or 37◦C. Appropriate BSL2 precautions were used when
handling live pathogens. For example, samples were spiked after
blending, and cultures were handled in screw-cap tubes, to reduce
aerosolization.
For the assay, incubations were all 1 h at room temperature, in
black microplates, swirling at 100 rpm. Washes were all threefold,
using phosphate-buffered saline (PBS), pH 7.4, containing 0.05%
Tween 20 (PBS-T) and a Bio-Plex Pro Wash Station (BioRad).
For each sample, a 100 µL aliquot was combined with 5000
of each type of microbead, then incubated and washed. The
microbeads were then resuspended in 100 µL of a cocktail
containing 4 µg/mL of each biotinylated detector Ab, then
incubated and washed. The microbeads were then resuspended
in 100 µL of 4 µg/mL streptavidin labeled with R-phycoerythrin
(SAPE), incubated and washed. The microbeads were finally
resuspended in 100 µL PBS and then analyzed on Luminex 100
or MAGPIX instruments.
For these experiments, we used overnight cultures, and
we were not concerned with assay sensitivity. We typically
recovered 50–90% of microbeads from samples, depending on
the matrix. We found that even 100 microbeads (instead of
5000) were sufficient for robust and reproducible signals. In
validation experiments performed with three strains of each of
the seven listed STEC serogroups, the assay gave 100% sensitivity
and specificity (Clotilde et al., 2013). When we expanded the
validation to include 161 environmental STEC strains our
Luminex immunoassay missed only one strain of O157. In this
latter experiment we compared performance of our assay to
standard assays and a microbead-based PCR serotyping assay
(Clotilde et al., 2015). This comparative study (Table 1) suggested
that our Luminex immunoassay also missed 10 strains of O111
and O128. However, these targets were not included in our 7-plex
immunoassay.
We have now further expanded our assay to include the
10 most common STEC in the US: O26, O45, O103, O111,
O121, O145, and O157, plus O91, O113, and O128. We still
observe excellent sensitivity and specificity. We believe that STEC
will continue to evolve additional pathogenic serogroups in the
future. Regulatory agencies currently base their actions on the
serogroup of such emerging adulterants, but there is consensus
toward surveillance of virulence factors, rather than O-antigens.
We already have working immunoassays for Stx (Clotilde et al.,
2011), and we plan to add intimin, a virulence factor involved in
E. coli attachment.
MOLECULAR SEROTYPING
The O antigen, a polymer of repeating oligosaccharides, is a
component of the lipopolysaccharide of gram negative bacteria,
and is used for serotyping E. coli into O serogroups. The wzx
flippase, and wzy polymerase genes code for proteins involved
in making the O antigen oligosaccharide, have proven to be O
serogroup specific, and thus excellent targets for O serogroup
specific PCR assays (Lin et al., 2011b). These genes were used to
develop a multiplex suspension array that can identify 11 STEC
O serogroups: O26, O45, O91, O103, O104, O111, O113, O121,
O128, O145, and O157 (Lin et al., 2013) (Figure 1B).
Primer and probe sequences from each of the 11 O serogroup
wzx or wzy genes were identified. Primers were designed with
one biotinylated primer, and one unlabeled primer to result
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TABLE 1 | List of disagreements between serotyping methods.
Luminex Additional serotyping
Strain # Conventional PCR Antibody Statens Remel
4 OUT O157 O157 O157
5 OUT O157 O157 O157
8 OUT O157 O157 O157
11 OUT O157 O157 O157
60 OUT O157 O157 O157
83 OUT O157 O157 O157
116 OUT O157 O157 O157
126 OUT O157 O157 O157
120 OUT O45 O45
25 OUT O111 – O111
32 OUT O111 – O111
69 O127 O128 – O128
71 O125 O128 – O128
72 O111 O128 – O128
73 O125 O128 – O128
74 O127 O128 – O128
75 O127 O128 – O128
77 O127 O128 – O128
70 O166 O128 and O121 O121 O128 and O121
86 O125 O157 O157 O157
105 O158 O157 O157 O157
88 O137 O111 O111 O111
85 O157 O157 –
OUT, other untypeable.
in a biotinylated amplicon. A single primer mix with primers
for all targets was prepared. PCR reactions were carried out
according to Lin et al. (2013). Signal to noise was improved
with asymmetric PCR amplification with concentrations of
biotinylated: unlabeled primer at a ratio of 5:1. Probe sequences
complimentary to the biotinylated strand were conjugated to
Luminex MagPlex R© microbeads according to the manufacturer’s
instructions (Luminex Corporation, 2007). After multiplex
PCR, amplicons were hybridized to labeled microbeads and
incubated with SAPE. Reactions were then analyzed with a
Luminex compatible cytometry-type instrument to interrogate
each uniquely colored microbead and detect the amount of
reporter molecule. Median fluorescent intensities (MFI’s) were
calculated for each analyte, and a signal to background ratio
was determined, where background is the MFI measured
using one or more wells containing all ingredients except
for template DNA. Signal to background ratio was calculated
using Bio-Plex Manager software as (Sample MFI-Background
MFI)/Background MFI. Samples are considered positive when
signal to background ratio is greater than 5.0.
The PCR based Luminex suspension array for O serotyping
has proven to be accurate, robust, and adaptable. A panel of
114 STEC isolates were all correctly identified, while 46 non-
STEC and non- E. coli yielded no false positives (Lin et al.,
2011a). In a multi-laboratory study of blind samples involving
nine laboratories, a total of 492 isolates were identified correctly
out of 495 analyzed (99.4% accuracy) (Lin et al., 2013). Another
advantage of the suspension array system and of PCR based
suspension arrays is the flexibility to add or remove targets from
the array as needed. For instance, the 11-plex suspension array
to identify 11 STEC O serogroups was recently modified to
include STEC attachment factors that may be important markers
of pathogenic potential. Primers and probes for the eae intimin
gene, and the aggR regulator of the enteroaggregative phenotype
have been added to the 11-plex O serotyping array to comprise a
13-plex STEC suspension array (Feng et al., 2015).
Suspension array technology allows for rapid, accurate, high
throughput analysis of STEC isolates. In addition to identifying
the most clinically relevant STEC O serogroups, the 13-plex
suspension array is able to detect the presence of adherence
factors that are associated with HUS, allowing regulatory and
public health labs to determine pathogenic potential. The
addition of the virulence factors to the suspension array also
illustrates the flexibility of suspension array technology. While
the big six STEC O serogroups and the O91, O128, O113, O104
additional O serogroups are presently the most concerning, new
emerging O serogroups could be added to the suspension array.
Additional targets could be added to the array, if other genes
prove to be more highly correlated with illness. For instance, the
H flagellar antigen is a useful phylogenetic marker (Ju et al., 2012)
and could be added to the array to indicate the full O and H
serotype. Other putative virulence factors that could be included
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in an STEC virulence profile include the plasmid-encoded
enterohemolysin (ehxA), STEC autoagglutinating adhesin (Saa),
extracellular serine protease (espP), long polar fimbria (lpf ), and
a bifunctional catalase-peroxidase (katP) (Law, 2000; Etcheverria
and Padola, 2013). Another area of future study is to evaluate
the effectiveness of the suspension array in screening food,
environmental, and clinical samples. A preliminary study of
artificially inoculated fresh produce and raw milk resulted in
over 90% agreement between the suspension array and qPCR
screening for stx1 and/or stx2 genes (Kase et al., 2015). Further
improvements such as including an internal amplification control
would be useful especially when screening enrichments to ensure
that PCR inhibition does not cause false negative results.
DISCUSSION
Both of these suspension array assays represent improvements in
speed and accuracy for detection and characterization of STEC
pathogens in foods. A unique feature of the microbead-based
immunoassay is that the magnetic microbeads pull down live
pathogens, concentrating them. We have found that positive
samples are easily cultured from the material remaining in
the assay microplate (Clotilde et al., 2011). This facilitates
further characterization, e.g., via molecular experiments. Other
possibilities include use of an orthogonal detection scheme, other
than SAPE. One group has combined immunomagnetic pull-
down on Luminex microbeads with a modified fluorescence in
situ hybridization (FISH) detection method (Stroot et al., 2012).
This capture antibody-targeted FISH assay (CAT-FISH) method
provides sensitivity equal to the Luminex immunoassay with the
possibility of additional specificity from the nucleic acid-based
FISH reporter. Among the many advantages of these suspension
arrays is the ability to quickly upgrade and enhance assays as new
genomic information becomes available for other pathotypes.
Beyond the addition of more informative targets, other potential
enhancements for these assays include workflow simplification,
improved reagent stability through lyophilization or stable,
engineered antibodies, and the ability to interrogate single cells
with the assay, which would enable the characterization of mixed
populations of STEC.
These assays fit on the spectrum of STEC characterization
techniques between single-plex PCR assays for rapid E. coli
screening of food samples and Next-Generation Sequencing
(NGS) techniques. NGS is benefitting assay developers by
providing information about novel molecular targets to more
completely characterize STEC samples. While NGS is a powerful
tool in microbiological research and outbreak investigations,
there is still a need for low-complexity multiplex assays to make
specific determinations about prioritized serogroups. One of
the most significant drawbacks to fluorescent microbead-based
methods is the cost of reagents, specifically the microbeads
themselves. If we test 100 samples with a 10-plex assay,
then 1000 assays are performed, and the cost per assay is
acceptable. However, if half of those samples are identified
as O157, then a more cost-effective work flow might begin
with slide agglutination for all samples, using a single-plex
O157 assay, followed by work-up of the non-O157 samples
using a more expensive multiplex assay. The tradeoff of this
workflow is that the time taken to do a full determination of
the non-O157 samples is increased significantly. The suspension
array technology still remains a versatile platform that benefits
research, industrial, and regulatory labs by enabling a variety
of protein and genetic analyses for many foodborne pathogens
of interest (e.g., sets of assays to identify and characterize
Salmonella, STEC, and foodborne toxins).
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